The Handbook of Nanomedicine – Kewal K. Jain – 3rd Edition

Rapid advances in nanobiotechnology and increasing translation to clinical nanomedicine have required a new edition since the second edition in 2012. The chapter titles have been retained along with some basic information, which is still retained, but most of the material has been replaced with new developments Important classical references have been left behind and new ones have been added Most advances have been in nanopharmaceuticals, particularly drug delivery using nanobiotechnology Nano-oncology remains the leading therapeutic area although considerable progress has been made in other therapeutic areas.

Several new nanobiotechnology-based products have been approved and some are in clinical trials. There is still an ongoing discussion on regulatory issues. Nanobiotechnology continues to play an increasingly important role in personalized medicine. The style of previous editions has been retained, and the terminology is kept simple for a diverse audience of physicians, scientists, and other interested individuals. The author wishes to acknowledge the help and encouragement received from David Casey, publisher’s editor, and Patrick J. Marton of Springer during the preparation of this book